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Abstract
Background: Presenilin-1 (PS1) is a transmembrane protein first discovered because of its association with familial
Alzheimer’s disease. Mice with null mutations in PS1 die shortly after birth exhibiting multiple CNS and non-CNS
abnormalities. One of the most prominent features in the brains of PS1−/− embryos is a vascular dysgenesis that
leads to multiple intracerebral hemorrhages. The molecular and cellular basis for the vascular dysgenesis in PS1−/−
mice remains incompletely understood. Because the extracellular matrix plays key roles in vascular development we
hypothesized that an abnormal extracellular matrix might be present in endothelial cells lacking PS1 and examined
whether the lack of PS1 affects expression of fibronectin a component of the extracellular matrix known to be
essential for vascular development.
Results: We report that primary as well as continuously passaged PS1−/− endothelial cells contain more fibronectin
than wild type cells and that the excess fibronectin in PS1−/− endothelial cells is incorporated into a fibrillar
network. Supporting the in vivo relevance of this observation fibronectin expression was increased in microvascular
preparations isolated from E14.5 to E18.5 PS1−/− embryonic brain. Reintroduction of PS1 into PS1−/− endothelial
cells led to a progressive decrease in fibronectin levels showing that the increased fibronectin in PS1−/−
endothelial cells was due to loss of PS1. Increases in fibronectin protein in PS1−/− endothelial cells could not be
explained by increased levels of fibronectin RNA nor based on metabolic labeling studies by increased protein
synthesis. Rather we show based on the rate of turnover of exogenously added biotinylated fibronectin that
increased fibronectin in PS1−/− endothelial cells results from a slower degradation of the fibronectin fibrillar matrix
on the cell surface.
Conclusions: These studies show that PS1 regulates the constitutive turnover of the fibronectin matrix in
endothelial cells. These studies provide molecular clues that may help to explain the origin of the vascular
dysgenesis that develops in PS1−/− embryonic mice.
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Background
Presenilin-1 is a polytopic transmembrane protein that
was first discovered because of its association with famil-
ial Alzheimer’s disease [1,2]. PS1 is highly conserved in
evolution having homologues in organisms as distant as
C. elegans, drosophila and lower chordates [3-5]. A
related gene, presenilin-2 also exists and mutations in
this gene also cause familial Alzheimer’s disease [1].
Within cells PS1 protein is located primarily in endo-
plasmic reticulum and Golgi membranes [6,7]. However
some protein is found in endosomes and on the surface
of cells as well as in the nuclear membrane and at syn-
aptic sites [8-10]. PS1 influences multiple molecular
pathways being best known for its role as a component
of the γ-secretase complex [2]. However PS1 also inter-
acts with other proteins in manners that do not involve
γ-secretase cleavage such as PS1’s well-studied inter-
action with β-catenin in which PS1 controls β-catenin
stability by favoring its stepwise phosphorylation leading
to its degradation [11].
Mice with null mutations in PS1 die within 30 min
after birth exhibiting multiple CNS and non-CNS
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abnormalities [12,13]. One of the most prominent fea-
tures in the developing brains is a vascular dysgenesis
that is associated with multiple intracerebral hemor-
rhages [12-15]. The molecular and cellular basis for the
vascular dysgenesis in PS1−/− mice remains incom-
pletely understood. The extracellular matrix plays a key
role in vascular development [16] which led us to
hypothesize that components of the extracellular matrix
might be altered by the absence of PS1.
Fibronectin is one key component of the extracellular
matrix. Many extracellular matrix proteins depend on
fibronectin for their incorporation into the matrix [17].
Within the extracellular matrix, fibronectin supports cell
adhesion in addition to playing functional roles in regu-
lating growth factor [18] and integrin related signaling
[17]. Fibronectin is essential for vascular development
and fibronectin null mutations in the mouse lead to em-
bryonic lethality with severe vascular defects [19].
Here we report that PS1−/− endothelial cells contain
more fibronectin than wild type cells. We further show
that fibronectin accumulates in PS1−/− endothelial cells
due to decreased turnover of the fibrillar fibronectin
matrix. These studies demonstrate a critical role for PS1
in regulating the formation of the extracellular matrix by
endothelial cells and may help to explain the basis for
the vascular dysgenesis found in PS1−/− mice.
Methods
Genetically modified mice
The PS1−/− mice utilized were those generated by Shen
et al. [12]. Genotyping was performed as previously
described [20]. Heterozygous mice were mated to pro-
duce PS1−/− embryos with the day a vaginal plug was
detected designated as E0.5. Pregnant female mice were
euthanized with carbon dioxide and PS1−/− embryos
were presumptively identified based on their gross dys-
morphic appearance. A portion of the body was saved
and used to isolate DNA and confirm genotypes. All
protocols were approved by the Institutional Animal
Care and Use Committee of the James J. Peters
Department of Veterans Affairs Medical Center (Bronx,
NY USA) and were conducted in conformance with
Public Health Service policy on the humane care and
use of laboratory animals and the NIH Guide for the
Care and Use of Laboratory Animals.
Generation of wild type and PS1−/− endothelial cell
cultures
Endothelial cells were prepared from E15.5 to E16.5 em-
bryonic brains. To maximize the yield the entire brain
was used to prepare cultures after removal of the menin-
ges. Endothelial cell cultures were prepared as described
previously [21]. Cultures were continuously passaged on
tissue culture dishes coated with murine collagen type
IV (BD Biosciences, Franklin Lakes, NJ, USA) in endo-
thelial cell growth medium (ECGM: DMEM-F12 supple-
mented with 10% heat-inactivated horse serum, 10%
heat-inactivated fetal calf serum, 100 μg/ml endothelial
cell growth supplement [BD Biosciences, Franklin Lakes,
NJ, USA], and 100 μg/ml heparin). Continuous cell lines
were established by continuously passing the cells at
high density (1:2 split ratio) in ECGM.
Preparation of embryonic microvessel fractions
Embryos from PS1−/− and wild type littermate controls
were collected at gestational ages ranging from E14.5 to
18.5. Brains were dissected, suspended in phosphate buf-
fered saline (PBS) and mechanically dissociated with a
fire-polished Pasteur pipette. The suspension was filtered
through a 75 μm nylon mesh filter. The microvessels
retained on the filter were extensively washed with cold
PBS and collected by centrifugation. To increase yields
two to three brains per genotype were pooled from each
litter.
Immunostaining
Endothelial cells were cultured on collagen IV coated
slides and fixed with 4% paraformaldehyde/PBS at room
temperature or with acetone/methanol (2:3 v/v) at −20°C.
Immunostaining was performed as previously described
[21] using the following antibodies: a rabbit polyclonal
anti-fibronectin (1:400; Sigma Aldrich, St. Louis MO,
USA), a rabbit polyclonal antibody against von Willebrand
factor (1:400; Sigma Aldrich) and a rat monoclonal anti
PECAM/CD31 (1:100; Millipore Billerica, MA USA) fol-
lowed by appropriate Alexa-conjugated secondary anti-
bodies (Invitrogen, Carlsbad, CA USA). Nuclei were
counterstained with 1 μg/ml 4',6-diamidino-2-phenylin-
dole (DAPI). When staining for biotinylated fibronectin,
cell cultures were incubated with Alexa conjugated-
streptavidin (1:300; Invitrogen). Images were acquired with
a Zeiss Axioplan or a Zeiss 700 confocal microscope
(Zeiss, Thornwood, NY USA). To quantitate levels of fibro-
nectin expression random fields were photographed under
the same exposure with a 20x lens on a Zeiss Axioplan
microscope. Images were analyzed with Adobe Photoshop
CS4 Extended v11.02 (Adobe Systems Incorporated, San
Jose, CA USA) using the analysis tool. Results were
expressed as fluorescence intensity/unit area/number of nu-
clei. Ten random fields containing approximately 100 cells
were counted.
For immunohistochemistry E15.5 embryonic brains
were collected, fixed overnight in 4% paraformaldehyde/
PBS and stored in PBS until sectioning. 50 μm thick sec-
tions were cut on a Leica VT1000 Vibratome (Vienna,
Austria). Sections were stained with the rabbit polyclonal
anti-fibronectin antibody described above (1:400) and
with biotin-labeled Bandeiraea (Griffonia) simplicifolia
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lectin (3μg/ml; BSI-B4, Sigma-Aldrich) as previously
described [15]. Sections were counterstained with DAPI.
Endothelial cell electroporation
Endothelial cells were trypsinized, washed with PBS and
resuspended in RPMI/10% fetal calf serum (electropor-
ation buffer). 400 μl aliquots containing approximately
3×105 cells were transferred to the electroporation cuv-
ettes (BTX Harvard Apparatus, Holliston, MA USA).
Plasmid DNA was added and the mixture chilled 10 min
at 4°C. Electroporation was performed with an ECM 830
generator (BTX, Harvard Apparatus) using one 200-volt
pulse applied for 40 msec. After a 5 min recovery at
room temperature the cells were plated in ECGM. An
expression ready plasmid containing human PS1 cDNA
was obtained from Genecopeia (Rockville, MD USA).
Western blot analysis
Cells or embryonic vessel preparations were lysed in a buf-
fer containing 50 mM Tris HCl pH 7.4, 150 mM NaCl, 1
mM EDTA, 1% Triton X-100, 0.5% Na deoxycholate, 0.5%
SDS containing protease inhibitors (Halt, Pierce, Rockford
IL USA) and phosphatase inhibitor cocktails 2 and 3
(Sigma-Aldrich). After a brief sonication, extracts were
centrifuged at 14,000 rpm for 20 min and the supernatants
collected. Protein concentration was determined with
the BCA reagent as described by the manufacturer
(Pierce). Western blotting was performed as previously
described [20]. The following antibodies were used:
a rabbit polyclonal anti-fibronectin (1:4000; Sigma
Aldrich), a rabbit monoclonal anti-vimentin (1:1500,
Cell Signaling, Danvers, MA, USA), a mouse monoclo-
nal antibody against the human PS1 N-terminal frag-
ment (NT.1; 1:500; gift of Dr. Paul Mathews, Nathan
Kline Institute, Orangeburg NY, USA) and a mouse
monoclonal antibody against the PS1 C-terminal frag-
ment (33B10, 1:1000; gift of Dr. Nikolaos Robakis,
Icahn School of Medicine at Mount Sinai, New York,
NY, USA). A rabbit polyclonal anti β-tubulin (1:5000;
Abcam, Cambridge UK) was used as loading control.
Deoxycholate solubility assay
Deoxycholate (DOC) solubility was assessed as described
in Wierzbicka-Patynowski et al. [22]. Endothelial cells
were grown in ECGM medium containing fibronectin-
depleted serum that had been prepared by chromatog-
raphy through gelatin-Sepharose [22]. The cells were
harvested after 48 hrs, lysed in DOC lysis buffer (2% Na
deoxycholate, 20 mM Tris HCl pH 8.8, 2 mM EDTA, 2
mM iodoacetic acid and 2 mM N-ethylmaleimide) and
the viscosity reduced by several passages though a 25g
needle. The lysate was centrifuged at 14,000 rpm for 30
minutes and the supernatant saved as the DOC soluble
fraction. The pellet (i.e. the DOC insoluble fraction) was
washed once in DOC lysis buffer, resuspended in lysis
buffer containing 1% SDS instead of 2% DOC and boiled
for 5 minutes. Protein concentration was determined
with the BCA reagent and the fractions were analyzed
by Western blotting.
Fibronectin biotinylation
Purified bovine plasma fibronectin 0.5 mg; Sigma Aldrich
was dialyzed against 0.5 M Na carbonate buffer, pH 8.5/
0.15 M NaCl overnight at 4°C. NHS-Biotin (Pierce) was
added (0.1 mg/ml) and the mixture incubated for 30 min
and dialyzed overnight against Tris-buffered saline [23].
Biotinylated fibronectin was added to cells at a concentra-
tion of 20 μg/ml. To determine the rate of degradation of
exogenously supplied fibronectin endothelial cells were
pulsed with biotinylated fibronectin (20 μg/ml) overnight.
The cells were then washed with PBS and harvested (0
time point) or switched to FN-depleted ECGM medium
and chased for 8 or 24 hrs at which time cells were
washed with PBS and the DOC soluble and insoluble frac-
tions were prepared. Samples were analyzed by Western
blotting probed with streptavidin-HRP (1:1000; Jackson
Immuno Research Laboratories, West Grow, PA USA) for
2 hrs and visualized with the ECL Prime reagent (GE
Healthcare).
Fibronectin labeling and immunoprecipitation
Cells were incubated with Expre35S35S-protein labeling
mix (Perkin-Elmer, Waltham MA, USA) in cysteine/me-
thionine free medium for different time intervals. At each
time point the medium was collected and the cells were
washed once with PBS and harvested. DOC soluble and
insoluble fractions were prepared as described above. The
samples were precleared with Agarose beads (Pierce) for 1
hr. Fibronectin was immunoprecipitated by addition of
2.0 μg of anti-fibronectin antibody (see above). After
overnight incubation at 4°C, 20 μl of protein A/G slurry
(Pierce) was added to capture the immune complexes.
The beads were washed 3 times with 25 mM Tris HCl
pH 7.4, 0.15 NaCl, 1mM EDTA, 1% NP-40, 5% glycerol
and the bound proteins eluted by addition of reducing
sample buffer. The eluted proteins were boiled for 10 min
and loaded onto a 7.5% SDS-PAGE gel. Gels were fixed
for 30 min with isopropanol/water/acetic acid 25/65/10
(v/v/v), and then treated with Amplify reagent (GE
Healthcare, Piscatawy, NJ USA) for 30 min, dried and
exposed to film.
RNA isolation and quantitative PCR (qPCR) analysis
Total RNA was isolated using the Rnaeasy kit (Ambion,
Austin, TX, USA) according to the manufacturer’s
instructions and treated with the DNA free reagent
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(Ambion) to remove any residual genomic DNA con-
tamination. 0.5-1μg of RNA was reverse transcribed
using the High Capacity cDNA reverse transcription kit
(Applied Biosystems, Foster City, CA USA). qPCR ana-
lysis was performed using predesigned Taqman gene ex-
pression assays (Applied Biosystems) for the selected
targets as described previously [20]. Normalization was
carried out using the geometric means of three genes:
peptidylprolyl isomerase A (Ppia), β-glucuronidase (Gusb)
and β-actin.
Statistical procedures
All data are presented as mean ± the standard error of the
mean. Equality of variance was assessed using the Levene
test. Comparisons were made using unpaired t tests (Stu-
dent’s t if the variances did not differ significantly, p > 0.05,
by Levene’s test; otherwise using the Welch correction for
unequal variances). Pearson correlations were also utilized.
Statistical tests were performed using the program
GraphPad Prism 5.0 (GraphPad Software, San Diego, CA
USA) or SPSS 20.0 (SPSS, Chicago, IL USA).
Results
PS1−/− endothelial cells contain more fibronectin than
wild type endothelial cells
One of the most prominent features in the brains of PS1
−/− embryos is the appearance of parenchymal hemor-
rhages. Associated with the vascular hemorrhages there is
a vascular dysgenesis [15]. In preliminary studies aimed at
examining whether components of the extracellular
matrix might be altered in PS1−/− mice we noted that
developing blood vessels in PS1−/− embryonic brain
Figure 1 Increased immunohistochemical staining of blood vessels in PS1−/− embryonic brain with fibronectin. Shown are neocortical
sections from E15.5 wild type (A, C, E) and PS1−/− (B, D, F) embryonic brain double stained with anti-fibronectin (FN) antibodies (C, D) and the
Bandeiraea (Griffonia) simplicifolia (BSI-B4) lectin (E, F). Panels A and B show DAPI staining of the same sections. Matched sections were
photographed under the same conditions. Note the increased vascular staining in the PS1−/− embryo with fibronectin compared to the lectin
staining which is equally intense in the wild type and PS1−/− embryo. Scale bar 50 μm.
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stained more prominently with fibronectin than wild type
embryos while vessels in wild type and PS1−/− brain were
visualized equally by the isolectin B4 (Figure 1).
To determine whether the increased fibronectin expres-
sion might reflect a primary overproduction of fibronectin
by PS1−/− endothelial cells, we examined fibronectin ex-
pression in endothelial cells cultured from wild type and
PS1−/− embryos. Primary endothelial cells were isolated
from E15.5-E16.5 brain using a procedure that we previ-
ously developed [21]. Characterization of the cells by
immunostaining showed that both wild type and PS1−/−
endothelial cells expressed the endothelial cell markers
PECAM-1 and von Willebrand factor (Figure 2). Cultures
from both wild type and PS1−/− embryos established ap-
parent continuous cell lines that have now been passaged
over 40 times and still retain their endothelial cell charac-
ter as indicated by the expression of PECAM-1 (data not
shown). Immunostaining for fibronectin showed that PS1
−/− endothelial cells had increased levels of fibronectin as
compared to wild type cells (Figure 3).
To examine fibronectin expression biochemically we
performed Western blotting on primary cultures of wild
type and PS1−/− endothelial cells. Total cell lysates were
prepared from cultures grown to confluency in fibronectin
depleted growth media. Western blot analysis showed that
total fibronectin was elevated in primary cultures of PS1
−/− endothelial cells 2–6 fold depending on the prepar-
ation. A representative blot from three independent
experiments is shown in Figure 4A,B. Fibronectin was also
increased in continuously passaged cell lines of endothelial
cells from PS1−/− embryos (Figure 4C).
Because it remained possible that the culturing of
endothelial cells was affecting the expression of fibronec-
tin we examined fibronectin expression in microvascular
preparations captured on nylon membranes from wild
type and PS−/− embryos. As shown in Figure 5, fibro-
nectin levels were increased in PS1−/− microvascular
preparations from E14.5 to E18.5 embryonic brain. By
contrast fibronectin levels were low and showed no dif-
ference between wild type and PS1−/− in the neuronal
Figure 2 Characterization of wild type and PS1−/− endothelial cells by immunostaining. Shown are primary cultures of wild type (A, C, E)
and PS1−/− endothelial cells (B, D, F) double stained for PECAM (C, D) and von Willebrand factor (E, F). Panels A and B show the same fields
stained for DAPI. Scale bar 20 μm.
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fraction that passed through the nylon filter from
embryos collected at E 15.5.
While clonal effects should not be an issue in primary
cell cultures, to show that the effects in passaged PS1
−/− endothelial cells was due to the loss of PS1 we rein-
troduced human PS1 into PS1−/− endothelial cells using
electroporation. Cells were electroporated with different
amounts of PS1 cDNA up to 40 μg and fibronectin
expression was examined 48 hrs post-transfection. As
shown in Figure 6, progressively higher levels of PS1 ex-
pression led to a progressive decrease in the level of fibro-
nectin expression consistent with the overexpression of
fibronectin in PS1−/− endothelial cells being due to the
loss of PS1. This experiment was independently replicated
twice using transfections of 20 μg of PS1 cDNA or empty
vector (data not shown). Collectively these results suggest
that lack of PS1 was associated with the increased
fibronectin.
Levels of fibronectin RNA in PS1−/− endothelial cells
Because increased fibronectin RNA levels might contrib-
ute to increases in fibronectin protein we determined
fibronectin RNA levels in wild type and PS1−/− endo-
thelial cells by qPCR. Figure 7 shows fibronectin RNA
Figure 3 Increased expression of fibronectin in PS1−/− endothelial cells by immunostaining. Shown are primary cultures of wild type
(A, B) and PS1−/− endothelial cells (C, D) immunostained for fibronectin (B, D). Panels A and C show the same fields stained for DAPI. In panel E,
fluorescence intensity of fibronectin staining was measured in wild type and PS1−/− cultures. Data are presented as fluorescence intensity/unit
area per number of nuclei counted which was acquired in ten random fields per culture. Asterisk indicates p < 0.05 vs. wild type (unpaired
t-test). Scale bar 20 μm.
Figure 4 Increased levels of fibronectin in PS1−/− endothelial cells by Western blotting. Primary cultures of wild type and PS1−/−
endothelial cells were grown to confluency in complete growth media containing fibronectin-depleted serum. The cells were harvested after
washing with PBS and total cell lysates were prepared. Western blotting was performed using an anti-fibronectin (FN) antibody (upper panel in
A). The middle panel shows the blot reprobed for β-tubulin (β-tub) as a loading control. The lowest panel in A shows the extracts probed with
the antibody 33B10 which recognizes the C-terminal fragment (CTF) of PS1 to confirm the lack of detectible PS1 expression in PS1−/−
endothelial cells. Panel B shows quantitation of the levels of fibronectin in the experiment shown in panel A. Asterisk indicates p < 0.05 vs. wild
type (unpaired t-test). In panel C, passage 38 wild type or PS1−/− endothelial cells were cultured as above overnight. Total cell lysates were
prepared and Western blotting was performed using an anti-fibronectin antibody (upper panel). Lower panel shows the blot reprobed for
β-tubulin. All lanes were loaded with 10 μg of total protein. Representative blots are shown from experiments that were independently replicated
three times.
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levels in both early and late passage endothelial cells. In
early passage (p2/p3) endothelial cells fibronectin RNA
was increased about 50% in PS1−/− compared to wild
type endothelial cells (p = 0.02, unpaired t-test). With
time in culture fibronectin RNA approximately doubled
in wild type endothelial cells between early passage (2/3)
and passage 43 (p = 0.0003). By contrast in PS1−/−
endothelial cells with time in culture fibronectin RNA
levels fell by over 50% between early passage (2/3) and
passage 41 (p = 0.002), this despite increased levels of
fibronectin protein in later passaged cells (Figure 4). p41
PS1−/− endothelial cells also had less that 1/3d the level
of fibronectin RNA found in p43 wild type endothelial
cells (p = 0.001), this despite fibronectin protein levels
being increased in later passaged (p38) PS1−/− com-
pared to wild type endothelial cells (Figure 4C). Thus
changes in fibronectin RNA levels correlate poorly with
changes in fibronectin protein levels with time in culture
and cannot explain the increase in fibronectin protein in
PS1−/− endothelial cells.
More fibrillar fibronectin is present in PS1−/− endothelial
cells
When secreted fibronectin binds to cells, dimeric fibro-
nectin is converted into a complex network of fibrils that
consist of high molecular weight aggregates. The fibronec-
tin found in PS1−/− endothelial cells appeared fibrillar
based on the pattern of immunocytochemical staining
(Figure 3). The fibrillar state of fibronectin can also be
monitored by isolation and quantitation of the relative
amounts of deoxycholate (DOC) soluble and insoluble ma-
terial [24,25]. Therefore we determined relative amounts of
Figure 5 Fibronectin levels are increased in microvascular preparations from PS1−/− embryonic brain. Microvascular preparations were
collected on nylon filters from brains of the indicated embryonic (e) ages. “neur” indicates the “neuronal” fraction that passed through the nylon
filer which was collected by centrifugation and then lysed for blotting. Blots were sequentially probed for fibronectin (FN) and β-tubulin (β-tub).
For comparison primary endothelial cell cultures (EC) were prepared and allowed to expand for two weeks before being cultured in serum free
growth media overnight and then harvested. 10 μg of protein was loaded per lane. A representative blot is shown from experiments that were
performed three times.
Figure 6 Reintroduction of PS1 into PS1−/− endothelial cells leads to decreased fibronectin expression. PS1−/− endothelial cells (p41),
grown to confluency were trypsinized, resuspended in electroporation buffer and electroporated with a plasmid carrying the human PS1 cDNA
or empty vector. In panel A, the expression of fibronectin was analyzed 48 hrs post-electroporation by Western blotting on cell lysates. 10 μg of
protein was loaded per lane. Blots were sequentially probed for fibronectin (FN), and β-tubulin (β-tub). The expression of PS1 was determined
with an antibody (NT.1) that is specific for the human (hPS1) N-terminal fragment of PS1 (NTF). The amount of electroporated cDNA (μg) is
indicated above each lane. Mock-transfected cells were electroporated with 40 μg of empty vector. In panel B, the experiment in panel A is
quantitated. A Pearson correlation coefficient showed that there was a significant negative correlation between the amount of PS1 plasmid
transfected and the level of expression of fibronectin (R2=0.8584; p=0.0237). This experiment was replicated twice using transfections of 20 μg of
PS1 cDNA or empty vector.
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fibronectin in DOC soluble and insoluble fractions as a
measure of fibrillar state. DOC soluble and insoluble frac-
tions were isolated from wild type and PS1−/− endothelial
cells (p3) grown to confluency in fibronectin depleted
medium and analyzed by Western blotting. Figure 8 shows
a representative blot from two independent experiments.
Both DOC soluble and insoluble material were increased in
PS1−/− endothelial cells. The ratio of DOC insoluble/DOC
soluble fibronectin was also similar in wild type and PS1
−/− cells (Figure 8C) indicating that the excess fibronectin
Figure 7 Levels of fibronectin RNA are not consistently changed in PS1−/− endothelial cells. In panel A, fibronectin RNA was measured in
endothelial cell cultures (n=3/genotype per passage) by qPCR for the passages indicated. Samples were run in triplicate and normalized to the
geometric means of Ppia, β-actin and Gusb. In panel B, the pooled data for passages 2 and 3 is presented. Statistically significant differences
(unpaired t-tests) are indicated above selected comparisons. Statistical comparisons are discussed further in the text.
Figure 8 The fibrillar state of fibronectin is increased in PS1−/− endothelial cells. Passage 3 wild type and PS1−/− endothelial cells were
grown to confluency in fibronectin-depleted medium. The endothelial cells were lysed with deoxycholate (DOC) lysis buffer and DOC-insoluble
material was isolated by centrifugation and analyzed by Western blot. In panel A, blots of DOC-insoluble and soluble material were sequentially
probed for fibronectin (FN) and vimentin (vim) or fibronectin and β-tubulin (β-tub). Panel B shows quantitation of the levels of DOC insoluble
fibronectin in the experiment shown in panel A. In panel C, the ratio of DOC insoluble/DOC soluble fibronectin is shown. Asterisk indicates p < 0.05
vs. wild type (unpaired t-test). 1 μg of protein was loaded per lane. A representative blot is shown from experiments that were performed twice.
De Gasperi et al. BMC Biochemistry 2012, 13:28 Page 8 of 14
http://www.biomedcentral.com/1471-2091/13/28
produced in PS1−/− endothelial cells is incorporated into a
fibrillar network.
Synthesis of fibronectin is not increased in PS1−/−
endothelial cells
Increased levels of fibronectin in PS1−/− endothelial
cells could reflect increased synthesis in the absence of
PS1. We determined the rate of fibronectin synthesis in
wild type and PS1−/− endothelial cells using metabolic
labeling. Endothelial cell proteins were labeled with 35S
cysteine/methionine for from 4 to 24 hours. At chosen
time points the amount of fibronectin was measured in
the culture medium as well as in the DOC soluble and
insoluble cellular fractions. As shown in Figure 9, levels
of fibronectin in the medium and DOC insoluble frac-
tion progressively increased from 4 to 24 hours in both
wild type and PS1−/− cultures while the level of DOC
soluble fibronectin remained constant from 4 to 24
hours. However levels of fibronectin in the medium of
PS1−/− endothelial cell cultures were approximately 50%
of those found in wild type cultures at each time point
while there was no difference between PS1−/− and wild
type cultures in the levels of fibronectin in the DOC sol-
uble or insoluble fractions. Thus these studies provide
no evidence for any increased fibronectin synthesis in
PS1−/− endothelial cells.
Figure 9 Lack of increased synthesis of fibronectin in PS1−/− endothelial cells. p43 wild type (wt) and p41 PS1−/− endothelial cells were
metabolically labeled with 35S cysteine/methionine. Fibronectin was immunoprecipitated from the culture medium as well as in the DOC soluble
and insoluble cellular fractions and levels were determined by fluorography. In panel A, duplicate experiments are shown where fibronectin was
measured after labeling for the indicated times (hours). In panel B, the results of the experiments in panel A are quantitated.
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Increased assembly of a fibronectin matrix on the surface
of PS1−/− endothelial cells
The above studies suggested that increased levels of
fibronectin in PS1−/− endothelial cells could not by
explained by increased synthesis. Rather they suggested
that PS1 might be influencing fibronectin matrix assem-
bly and maturation. Fibronectin matrix assembly begins
with secretion of soluble fibronectin dimers that associ-
ate into fibrils and then a fibrillar network [17,26]. This
process can be monitored by following the processing of
exogenously added fibronectin to cells. Wild type and
PS1−/− endothelial cells were loaded overnight with
biotinylated fibronectin. Binding was firstly assessed by
staining cells with fluorescently labeled streptavidin. As
shown in Figure 10, after an overnight exposure PS1−/−
endothelial cells contained grossly more biotinylated
fibronectin bound to the cell surface that appeared to be
assembled into a fibrillar network.
To determine whether the bound fibronectin was
assembled into a fibrillar network biochemically, DOC sol-
uble and insoluble fractions were prepared and analyzed
by Western blotting. As shown in Figure 11, biotinylated
fibronectin was proportionately increased in both DOC-
soluble and insoluble fractions isolated from PS1−/−
Figure 10 Increased binding of biotinylated fibronectin to PS1−/− endothelial cells. p43 wild type (A, C, E) and p41 PS1−/− (B, D, F)
endothelial cells were loaded overnight with 20 μg/ml of biotinylated fibronectin. Cells were fixed and stained with Alexa488-conjugated
streptavidin and then imaged by confocal microscopy. Panels A and B show cultures labeled for biotinylated fibronectin. Panels C and D show
the same fields stained for DAPI and merged images are shown in panels E and F. Scale bar 10 μm.
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endothelial cells suggesting that more fibronectin was
being held in an assembled matrix on the cell surface of
PS1−/− endothelial cells.
Turnover of biotinylated fibronectin is reduced in PS1−/−
endothelial cells
The above studies suggested that rather than affecting
synthetic rate, the absence of PS1 was affecting the rate
of fibronectin turnover on the cell surface. To determine
the turnover rate of fibronectin on the cell surface, wild
type and PS1−/− endothelial cells were loaded overnight
with biotinylated fibronectin and the relative amounts of
fibronectin in the DOC soluble and insoluble fractions
were determined at 0, 8 and 24 hours after labeling. As
shown in Figure 12, biotinylated fibronectin disappeared
from PS1−/− cells more slowly than in endothelial cells
containing PS1. These results indicate that decreased
turnover of the fibronectin matrix best explains the
increased levels of fibronectin found in PS1−/− endothe-
lial cells.
Discussion
Fibronectin is a modular protein that is derived from a
single gene which can be alternatively spliced into 20
possible monomeric forms in man and up to 12 in
mouse [17]. Fibronectin exists in a cellular form that is
present in tissues and assembled into a fibrillar matrix,
as well as a plasma form that is produced by the liver
and secreted into the blood where it is soluble and non-
fibrillar [26]. The assembled fibronectin matrix binds
other components of the extracellular matrix [27].
Within the extracellular matrix, fibronectin supports cell
adhesion but plays other functional roles as well such as
its role in regulating activation of latent complexes con-
taining the transforming growth factor-β [18,28].
Here we show that PS1 regulates fibronectin levels in
endothelial cells by modulating the constitutive turnover
of the fibronectin matrix. PS1−/− endothelial cells con-
tained more fibronectin protein that assembled into a fi-
brillar network. The increased fibronectin protein could
not be explained by altered levels of fibronectin RNA
nor by increased protein synthesis. Rather the increased
fibronectin in PS1−/− endothelial cells resulted from a
slower rate of degradation of the fibrillar fibronectin
matrix assembled on the cell surface.
Fibronectin matrix assembly begins with secretion of
soluble fibronectin dimers ( reviewed in [17] ) that bind
to integrin receptors on the cell surface. Then in a
process that is still incompletely understood fibronectin
to fibronectin associations occur that lead to fibril
formation and production of a fibrillar network [17].
Integrins are a family of cell surface receptors composed
of non-covalently linked heterodimers composed of α
and β subunits [29,30]. Integrin α5β1 is the major fibro-
nectin receptor although other integrins can perform
this function in some circumstances [31,32]. Integrins
signal through a dynamic spatially and temporally con-
trolled process that involves assembly of multiprotein
complexes through their cytoplasmic tails [33].
Following fibronectin binding to an integrin receptor,
bound fibronectin is first diffusely localized on the cell
surface [17]. Fibronectin binding promotes receptor
clustering and the dimeric fibronectin becomes orga-
nized into short fibrils that are initially DOC soluble
[17]. Thin fibrils lengthen and are converted into a DOC
insoluble form.
Integrin receptor activation further leads to the cyto-
plasmic domains of integrins becoming associated with
and activating the cytoskeleton. During this process
complexes containing α5β1 integrin, focal adhesion
kinase (FAK), vinculin, and paxillin form at sites of
fibronectin fibril assembly leading to activation of FAK,
the recruitment and activation of Src family kinases and
activation of the phosphoinositide 3-kinase (PI3K) path-
way among others [33,34].
Where PS1 is acting in the molecular events that regu-
late fibronectin matrix turnover is unclear. PS1 has been
reported to affect maturation of the β1 integrin subunit
in fibroblasts [35]. However, in exploring levels of integ-
rins in PS1−/− endothelial cells we have not found any
consistent changes in levels of the α5 or β1 subunits
(unpublished observations). Functionally PS1 is best
Figure 11 Increased levels of DOC insoluble biotinylated
fibronectin following loading of PS1−/− endothelial cells.
Passage 2 cultures of wild type (wt) and PS1−/− endothelial cells
were grown in fibronectin-depleted serum and were loaded with
biotinylated fibronectin (Biot-FN: 20 μg/ml) for the indicated times
(hours). DOC-soluble and insoluble fractions were prepared and
analyzed by Western blot. The membranes were probed with
peroxidase conjugated-streptavidin and the DOC insoluble fraction
was reprobed for vimentin (vim) while the DOC soluble fraction was
reprobed for β-tubulin (β-tub). 1 μg of protein was loaded per lane.
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known for its role as a component of the γ-secretase
complex which is known to cleave more than 60 trans-
membrane proteins [2]. Therefore PS1 could be regulat-
ing fibronectin turnover if it affected signaling through
integrin receptors. Integrins are transmembrane proteins
made of α/β heterodimers with each subunit having a
large extracellular domain, a single transmembrane helix
and a short cytoplasmic segment [36]. There is currently
no evidence that integrin subunits are cleaved by γ-
secretase. However, PS1 influences some of the known
pathways regulated by integrin signaling. For example
PS1 has been reported to enhance signaling through
the PI3K/Akt pathway by associating with the p85 regu-
latory subunit of PI3K [37,38] although why this inter-
action should affect turnover of the fibronectin matrix
is unclear. Fibronectin matrix turnover also occurs
through a caveolin-1 dependent process [39] and
caveolin-1 dependent trafficking has been reported to
be affected by the absence of PS1 [40] providing another
mechanism whereby PS1 could affect fibronectin matrix
remodeling.
Conclusions
Future studies will be needed to determine how PS1
affects remodeling of the fibronectin matrix at the cell sur-
face. However whatever its mechanism of action, these
studies show that PS1 is essential for the constitutive re-
modeling of the fibronectin matrix in endothelial cells.
The extracellular matrix plays crucial roles in the develop-
ment and function of the cerebral vasculature [16] and
fibronectin is essential for normal vasculogenesis with the
absence of fibronectin leading to severe embryonic vascu-
lar defects [19]. Whether ineffective remodeling of the
fibronectin matrix may help to explain the vascular dys-
genesis in the brains of PS1−/− embryos is as yet unclear.
However, these studies suggest molecular clues to the ori-
gins of the vascular dysgenesis found in PS1−/− embry-
onic mice that can be explored in future studies.
Figure 12 Delayed turnover of the fibronectin matrix in PS1−/− endothelial cells. Endothelial cells (p44) were pulsed with biotinylated
fibronectin overnight and then switched to FN depleted medium and chased for the indicated times (hrs). At each time point the DOC soluble
and insoluble fractions were prepared. One μg (insoluble) or 4 μg (soluble) samples were analyzed for biotinylated-FN by Western blotting using
streptavidin-HRP. Samples were probed for vimentin (vim) and β-tubulin (β-tub) by Western blotting as controls for extraction of the insoluble
and soluble fractions. Two independent replicates are shown.
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